Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 28, 2001

View Archived Issues

Actelion Gains FDA Approval Of Tracleer For PAH Indication

Private Companies Should Secure Funding While The Money Is There

Progen Expanding PI-88 Plan, Moving Into Leukemia Trials

Unique Metabolism Of Parasite Could Yield Drugs, Diagnostics

Parliament Prepares For Another Broad Debate On Biotechnology

Cerep, Aventis Pharma Join To Push Kinase Inhibitors

Germany Fuels Brain Proteome Work Through DM20.5M Grant

Genfit Enters Collaborations With French Pharma Companies

Peptor Vaccine Shows Promise In Study Of Type I Diabetics

Pieris Anticalin Library Offers Alternatives To Antibody Work

CAT Contracts With Lonza For Manufacture Of Antibodies

NeuroSearch Spin-Off Targets Lung Disease, Allergies, More

Galapagos, Pharmacia In Deal For Gene Target Identification

ACE BioSciences, LIONs First Database Product Due In Spring

Israeli Government Puts $250M Toward Boosting Biotechnology

Other News To Note

Oxford Gene Gets Positive Ruling From Patent Office

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...